Stock Price
32.46
Daily Change
0.64 2.01%
Monthly
2.82%
Yearly
5.12%
Q3 Forecast
31.18



Peers Price Chg Day Year Date
Ansell 32.46 0.64 2.01% 5.12% Jul/27
Cochlear 114.50 2.89 2.59% -63.88% Jul/27
CSL 116.39 2.17 1.90% -56.99% Jul/27
Fisher Paykel Healthcare 39.88 0.46 1.17% 9.05% Jul/27
Amotiv 6.71 0 0% -24.52% Jul/27
Healius 0.35 -0.01 -1.43% -57.41% Jul/27
Integral Diagnostics 2.05 0 0% -24.63% Jul/27
Mayne Pharma 2.63 -0.08 -2.95% -49.90% Jul/27
Nanosonics 2.99 0.01 0.34% -24.69% Jul/27
Polynovo 0.82 -0.04 -4.68% -34.27% Jul/27

Indexes Price Day Year Date
ASX200 8852 121.69 1.39% 1.78% Jul/27
ASX All Share 9064 122.30 1.37% 1.12% Jul/27

Ansell traded at 32.46 this Monday July 27th, increasing 0.64 or 2.01 percent since the previous trading session. Looking back, over the last four weeks, Ansell gained 2.82 percent. Over the last 12 months, its price rose by 5.12 percent. Looking ahead, we forecast Ansell to be priced at 31.18 by the end of this quarter and at 29.34 in one year, according to Trading Economics global macro models projections and analysts expectations.

Ansell Limited is an Australia-based safety protection solutions Company. It is engaged in development, manufacturing, sourcing, and distributing of gloves and personal protective equipments. The Company operates through two segments: Industrial Global Business Unit (GBU) and Healthcare Global Business Unit (GBU). Industrial GBU manufactures hand and chemical protective clothing solutions for industrial applications. Industrial GBU offers protective solutions to various industries such as automotive, chemical, metal fabrication, machinery and equipment, food, construction, mining, oil, and gas. Healthcare GBU manufactures surgical and examination gloves, healthcare safety devices and infection prevention products for healthcare professionals and patients and single use industrial application gloves. Healthcare GBU offers solutions to customers including hospitals, dental surgeries, veterinary clinics, auto repair shops, chemical plants, laboratories, and pharmaceutical companies.